143 related articles for article (PubMed ID: 22707223)
41. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
42. Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation.
Cowled P; Kanter I; Leonardos L; Jackson P
Neoplasia; 2005 Dec; 7(12):1091-103. PubMed ID: 16354592
[TBL] [Abstract][Full Text] [Related]
43. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
[TBL] [Abstract][Full Text] [Related]
44. DNA methylation patterns in bladder tumors of African American patients point to distinct alterations in xenobiotic metabolism.
Vantaku V; Amara CS; Piyarathna DWB; Donepudi SR; Ambati CR; Putluri V; Tang W; Rajapakshe K; Estecio MR; Terris MK; Castro PD; Ittmann MM; Williams SB; Lerner SP; Sreekumar A; Bollag R; Coarfa C; Kornberg MD; Lotan Y; Ambs S; Putluri N
Carcinogenesis; 2019 Nov; 40(11):1332-1340. PubMed ID: 31284295
[TBL] [Abstract][Full Text] [Related]
45. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
46. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
[TBL] [Abstract][Full Text] [Related]
47. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
48. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
[TBL] [Abstract][Full Text] [Related]
49. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Spicuglia S
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
[TBL] [Abstract][Full Text] [Related]
50. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
51. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
[TBL] [Abstract][Full Text] [Related]
52. The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.
Ouerhani S; Elgaaied AB
Cancer Biomark; 2011-2012; 10(6):259-66. PubMed ID: 22820081
[TBL] [Abstract][Full Text] [Related]
53. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Salvatore S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
[TBL] [Abstract][Full Text] [Related]
54. Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.
Ozden S; Turgut Kara N; Sezerman OU; Durasi İM; Chen T; Demirel G; Alpertunga B; Chipman JK; Mally A
Toxicol Appl Pharmacol; 2015 Dec; 289(2):203-12. PubMed ID: 26431795
[TBL] [Abstract][Full Text] [Related]
55. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
56. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.
Jackson P; Millar D; Kingsley E; Yardley G; Ow K; Clark S; Russell PJ
Cancer Lett; 2000 Sep; 157(2):169-76. PubMed ID: 10936677
[TBL] [Abstract][Full Text] [Related]
57. The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.
Zeng F; Heng J; Guo X; Wang Y; Wu W; Tang L; Chen M; Wang S; Deng H; Wang J
Breast Cancer Res Treat; 2020 Feb; 180(1):237-245. PubMed ID: 31983017
[TBL] [Abstract][Full Text] [Related]
58. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
Abdolmaleky HM; Cheng KH; Russo A; Smith CL; Faraone SV; Wilcox M; Shafa R; Glatt SJ; Nguyen G; Ponte JF; Thiagalingam S; Tsuang MT
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):60-6. PubMed ID: 15717292
[TBL] [Abstract][Full Text] [Related]
59. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
60. Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
Zhan L; Zhang B; Tan Y; Yang C; Huang C; Wu Q; Zhang Y; Chen X; Zhou M; Shu A
Medicine (Baltimore); 2017 Feb; 96(7):e6097. PubMed ID: 28207521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
